For the Inventor, By the Inventor

Enter assignee name

Edmonton, Canada

Isotechnika Inc.

Calculating rank

USPTO Granted Patents = 30

% Expired Patents = 33.3

CIPO Patents = 5

EPO Patents = 1

Forward Citations = 1,859

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Robert T Foster (28 out of 37 patents)

Randall W Yatscoff (23 out of 33 patents)

Selvaraj A Naicker (14 out of 28 patents)

4. Richard Lewanczuk (9 out of 9 patents)

5. Launa J Aspeslet (6 out of 6 patents)

6. Gilles Caille (3 out of 3 patents)

7. Mark D Abel (2 out of 4 patents)

8. Jean-Michel Adam (1 out of 15 patents)

9. Bruno Lohri (1 out of 13 patents)

10. Roman Szweda (1 out of 7 patents)

11. Daniel Trepanier (1 out of 1 patent)

12. Seetharaman Jayaraman (1 out of 1 patent)

13. Hans-Jürgen Mair (1 out of 2 patents)

14. S Selvaraj Naicker (1 out of 2 patents)

15. Salvaraj Naicker (1 out of 1 patent)

Core Competencies:

Cyclosporin Analog

Deuterated Compounds

Rapamycin Derivatives

Immunomodulating Agents

Diabetes Diagnostics

Calcium Channel Blockers

Cancer Treatment

Pharmacological Treatment

Glucose Breath Test

Activated Iododerivatives

Medicinal Composition

Amlodipine

30 patents: Sort by Forward Citations

1. 7829533 - Cyclosporin analog formulations (2010-11-09),

2. 7538189 - Methods of making deuterated cyclosporin analogs (2009-05-26),

3. 7521421 - Deuterated cyclosporine analogs and methods of making the same (2009-04-21),

4. 7429562 - Cyclosporin analog formulations (2008-09-30),

5. 7358229 - Deuterated cyclosporin analogs and their use as immunomodulating agents (2008-04-15),

6. 7332472 - Cyclosporine analogue mixtures and their use as immunomodulating agents (2008-02-19),

7. 7160867 - Rapamycin carbohydrate derivatives (2007-01-09),

8. 7141648 - Synthesis of cyclosporin analogs (2006-11-28),

9. 7118919 - 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control (2006-10-10),

10. 7060672 - Cyclosporin analog formulations (2006-06-13),

11. 6998385 - Cyclosporine analogue mixtures and their use as immunomodulating agents (2006-02-14),

12. 6878550 - 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control (2005-04-12),

13. 6818200 - Method of using deuterated calcium channel blockers (2004-11-16),

14. 6780995 - Activated iododerivatives for the treatment of cancer and aids (2004-08-24),

15. 6686454 - Antibodies to specific regions of cyclosporine related compounds (2004-02-03),

Company Overview

Isotechnika Inc. is a biotechnology company based in Edmonton, Canada, specializing in the development of innovative therapeutic solutions. The organization focuses on advancing treatments primarily in the fields of immunology and transplantation. With a commitment to research and development, Isotechnika aims to address unmet medical needs through its proprietary technologies and drug candidates, contributing to improved patient outcomes in the healthcare sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

30 Patents

#9 in Edmonton

#463 in Canada

#21,924 in the World

Edmonton, Canada

Isotechnika Inc.

Forward Citations = 1,859

17 inventors:

Robert T Foster (28 out of 37 patents)

Randall W Yatscoff (23 out of 33 patents)

Selvaraj A Naicker (14 out of 28 patents)

4. Richard Lewanczuk (9 out of 9 patents)

5. Launa J Aspeslet (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Isotechnika Inc.. Retrieved from https://idiyas.com/company/isotechnika

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…